Literature DB >> 1668107

Effect of platelet-activating factor on tumor necrosis factor-induced superoxide generation from human neutrophils. Possible involvement of G proteins.

P Braquet1, D Hosford, P Koltz, J Guilbaud, M Paubert-Braquet.   

Abstract

The effect of platelet-activating factor (PAF) and of two specific PAF antagonists on tumor necrosis factor (TNF) induced superoxide production by human polymorphonuclear neutrophils (PMN) was examined. PAF alone (0.1 pM to 0.1 nM) failed to evoke superoxide production; however, when PAF was added for 10 min to cells upon prior incubation with 10 ng/mL TNF for 50 min, superoxide production was significantly enhanced as compared to that induced by TNF alone. Maximum amplification (+30%) was obtained with 10 pM PAF; however, the effect was completely abolished by two structurally unrelated PAF antagonists, BN 52021 and BN 52111. The antagonists also decreased by 25% the superoxide production elicited solely by TNF, implicating the involvement of endogenous PAF in this process. Pretreatment of the PMN with either pertussis or cholera toxin attenuated the PAF amplified superoxide production in TNF stimulated cells, suggesting that G proteins sensitive to these toxins may be involved in the mechanisms controlling amplification.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1668107     DOI: 10.1007/bf02536504

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.880


  19 in total

1.  Enhancement of neutrophil superoxide production by preincubation with recombinant human tumor necrosis factor.

Authors:  R L Berkow; D Wang; J W Larrick; R W Dodson; T H Howard
Journal:  J Immunol       Date:  1987-12-01       Impact factor: 5.422

2.  Bowel necrosis induced by tumor necrosis factor in rats is mediated by platelet-activating factor.

Authors:  X M Sun; W Hsueh
Journal:  J Clin Invest       Date:  1988-05       Impact factor: 14.808

Review 3.  The role of cachectin/TNF in endotoxic shock and cachexia.

Authors:  A Cerami; B Beutler
Journal:  Immunol Today       Date:  1988-01

Review 4.  PAF/cytokine auto-generated feedback networks in microvascular immune injury: consequences in shock, ischemia and graft rejection.

Authors:  P Braquet; M Paubert-Braquet; R H Bourgain; F Bussolino; D Hosford
Journal:  J Lipid Mediat       Date:  1989 Mar-Apr

5.  Effect of cyclic AMP on release of lysosomal enzymes from phagocytes.

Authors:  G Weissmann; P Dukor; R B Zurier
Journal:  Nat New Biol       Date:  1971-06-02

Review 6.  Roles of G protein subunits in transmembrane signalling.

Authors:  E J Neer; D E Clapham
Journal:  Nature       Date:  1988-05-12       Impact factor: 49.962

Review 7.  Perspectives in platelet-activating factor research.

Authors:  P Braquet; L Touqui; T Y Shen; B B Vargaftig
Journal:  Pharmacol Rev       Date:  1987-06       Impact factor: 25.468

8.  Effect of recombinant DNA-produced tumor necrosis factor on various parameters of neutrophil function.

Authors:  Y Ozaki; T Ohashi; Y Niwa; S Kume
Journal:  Inflammation       Date:  1988-08       Impact factor: 4.092

9.  Granulocyte-macrophage colony-stimulating factor modulates the excitation-response coupling sequence in human neutrophils.

Authors:  P H Naccache; N Faucher; P Borgeat; J C Gasson; J F DiPersio
Journal:  J Immunol       Date:  1988-05-15       Impact factor: 5.422

10.  Tumor necrosis factor/cachectin stimulates peritoneal macrophages, polymorphonuclear neutrophils, and vascular endothelial cells to synthesize and release platelet-activating factor.

Authors:  G Camussi; F Bussolino; G Salvidio; C Baglioni
Journal:  J Exp Med       Date:  1987-11-01       Impact factor: 14.307

View more
  5 in total

Review 1.  Clinical experience with platelet-activating factor antagonists. Past, present, and near future.

Authors:  P Guinot
Journal:  Clin Rev Allergy       Date:  1994

Review 2.  Platelet-activating factor antagonists.

Authors:  M Koltai; P G Braquet
Journal:  Clin Rev Allergy       Date:  1994

Review 3.  Current Status of Primary, Secondary, and Tertiary Prevention of Coronary Artery Disease.

Authors:  Kailash Prasad
Journal:  Int J Angiol       Date:  2021-08-25

4.  Inhibition of tumor necrosis factor-alpha by thalidomide in magnesium deficiency.

Authors:  W B Weglicki; R E Stafford; B F Dickens; I T Mak; M M Cassidy; T M Phillips
Journal:  Mol Cell Biochem       Date:  1993-12-22       Impact factor: 3.396

Review 5.  Toxins-useful biochemical tools for leukocyte research.

Authors:  Susana Cubillos; Johannes Norgauer; Katja Lehmann
Journal:  Toxins (Basel)       Date:  2010-03-26       Impact factor: 4.546

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.